Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Severe Coronavirus Disease 2019)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04653831
What this trial is testing

Treatment With Pirfenidone for COVID-19 Related Severe ARDS

Who this might be right for
Covid19ARDS
Soroka University Medical Center 26
Not applicableUnknownNCT05665153
What this trial is testing

Symphony IL-6 Study in Patients at Risk of Severe Sepsis

Who this might be right for
Severe Sepsis
Bluejay Diagnostics, Inc. 200
Large-scale testing (Phase 3)Study completedNCT04409262
What this trial is testing

Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Hoffmann-La Roche 649
Not applicableUnknownNCT06033560
What this trial is testing

The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure

Who this might be right for
COVID-19Hypoxemic Respiratory Failure
Amsterdam UMC, location VUmc 6,000
Not applicableStudy completedNCT04343053
What this trial is testing

Pro-thrombotic Status in Patients with SARS-Cov-2 Infection

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
University Hospital of Ferrara 145
Testing effectiveness (Phase 2)WithdrawnNCT05018975
What this trial is testing

Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release Syndrome
Loma Linda University
Not applicableStudy completedNCT04919031
What this trial is testing

Inspiratory Muscle Trainer and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Persistent Symptoms

Who this might be right for
Covid19HypertensionCorona Persistent Symptoms
Cairo University 90
Testing effectiveness (Phase 2)Ended earlyNCT04347226
What this trial is testing

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

Who this might be right for
Solid TumorSars-CoV2Hematological Malignancy
Columbia University 43
Not applicableStudy completedNCT04450017
What this trial is testing

Clinical Features of Severe Patients With COVID-19

Who this might be right for
SARS-CoV2
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 200
Not applicableUnknownNCT04446338
What this trial is testing

Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre

Who this might be right for
History of Covid-19, Seroprevalence
University Hospital Tuebingen 300
Not applicableUnknownNCT04522037
What this trial is testing

Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients

Who this might be right for
Patients Hospitalized in the Hospices Civils of LyonCOVID-19 DiseaseModerate to Severe Dyspnea+1 more
Hospices Civils de Lyon 200
Early research (Phase 1)Study completedNCT04507256
What this trial is testing

AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19

Who this might be right for
COVID-19
AstraZeneca 60
Large-scale testing (Phase 3)WithdrawnNCT05157243
What this trial is testing

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Who this might be right for
COVID-19
Romark Laboratories L.C.
Large-scale testing (Phase 3)Study completedNCT04822818
What this trial is testing

EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19

Who this might be right for
Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)Virus Diseases+5 more
Assistance Publique - Hôpitaux de Paris 96
Not applicableStudy completedNCT02788903
What this trial is testing

A Patient-Centered PaTH to Addressing Diabetes

Who this might be right for
ObesityDiabetesCovid19
Milton S. Hershey Medical Center 2,622,164
Not applicableStudy completedNCT04906850
What this trial is testing

Evaluation of the New Variant 501Y.V2 of COVID-19

Who this might be right for
Covid19
Centre Hospitalier Régional Metz-Thionville 250
Testing effectiveness (Phase 2)Study completedNCT04830020
What this trial is testing

Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes

Who this might be right for
Covid19
Campus Bio-Medico University 180
Testing effectiveness (Phase 2)Study completedNCT04476979
What this trial is testing

Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19

Who this might be right for
Coronavirus InfectionSARS (Severe Acute Respiratory Syndrome)Virus Diseases+5 more
Assistance Publique - Hôpitaux de Paris 453
Not applicableEnded earlyNCT05252910
What this trial is testing

Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents

Who this might be right for
COVID-19
Pharm-Olam, LLC 33
Large-scale testing (Phase 3)Ended earlyNCT05011513
What this trial is testing

Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).

Who this might be right for
COVID-19
Pfizer 1,440
Next Page